Acción INBP INTEGRATED BIOPHARMA, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Integrated BioPharma, Inc.

Acciones

INBP

US45811V1052

Diferido OTC Markets
Otros sitios de cotización
 16:44:13 23/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,22 USD 0,00 % Gráfico intradía de Integrated BioPharma, Inc. 0,00 % -10,28 %
10/05 Integrated BioPharma, Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de marzo de 2024 CI
12/02 Integrated BioPharma, Inc. informa de los resultados del segundo trimestre y de los seis meses finalizados el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción INBP
  4. Noticias Integrated BioPharma, Inc.
  5. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA